Skip to main content
. 2019 Mar 27;15(1):52–58. doi: 10.5114/aic.2019.83652

Table I.

Study population and procedural data (n = 50)

Parameter Value
Age [years] 66.0 ±9.3
Male sex 36 (72.0)
Height [cm] 169.9 ±7.9
Weight [kg] 80.4 ±13.3
Body mass index [kg/m2] 27.8 ±3.7
Arterial hypertension 50 (100.0)
Diabetes mellitus 28 (56.0)
Previous myocardial infarction 26 (52.0)
Previous PCI 24 (48.0)
Previous CABG 0 (0.0)
Peripheral arterial disease 2 (4.0)
Chronic obstructive pulmonary disease 1 (2.0)
Previous stroke/TIA 0 (0.0)
Hyperlipidemia 50 (100.0)
Smoking 20 (40.0)
Serum creatinine [µmol/l] 91.1 ±19.4
LVEF (%) 52.8 ±8.1
Heart rate [beat/min] 71.5 ±9.7
Angina symptoms – CCS class:
 I 6 (12.0)
 II 40 (80.0)
 III 4 (8.0)
Heart failure symptoms – NYHA class:
 I 43 (86.0)
 II 5 (10.0)
 III 1 (4.0)
 IV 1 (4.0)
Access:
 Radial 35 (70.0)
 Femoral 15 (30.0)
Number of assessed vessels 3.0 (2.0–4.0)
Scheduled treatment:
 Conservative 21 (42.0)
 PCI 23 (46.0)
 CABG 6 (12.0)

Values presented as number (percentage), mean ± standard deviation or median (interquartile range). CABG – coronary artery bypass grafting, CCS – Canadian Cardiovascular Society, LVEF – left ventricle ejection fraction, NYHA – New York Heart Association, PCI – percutaneous coronary intervention, TIA – transient ischemic attack.